- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 20.89M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 20.94M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.48M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $220K |
| Capex | Q1 2025 · Mar 31, 2024 | $90K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$42.77M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$23.25M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $33.92M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $65.04M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $49.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $60.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $149.61M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $26.42M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $70.71M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $163.68M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $67.22M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $25.09M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $22.9M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $111.23M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $109.13M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $89.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $131.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $137.65M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $179.84M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$2.25 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.65 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$2.25 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.65 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $19.47M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $13.79M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $28.75M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $15.41M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$47.02M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$27.15M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$48.22M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$29.2M |